Literature DB >> 19018031

Intestinal TM7 bacterial phylogenies in active inflammatory bowel disease.

Tanja Kuehbacher1, Ateequr Rehman2, Patricia Lepage2, Stephan Hellmig1, Ulrich R Fölsch1, Stefan Schreiber2,1, Stephan J Ott2,1.   

Abstract

TM7 is a recently described subgroup of Gram-positive uncultivable bacteria originally found in natural environmental habitats. An association of the TM7 bacterial division with the inflammatory pathogenesis of periodontitis has been previously shown. This study investigated TM7 phylogenies in patients with inflammatory bowel diseases (IBDs). The mucosal microbiota of patients with active Crohn's disease (CD; n=42) and ulcerative colitis (UC; n=31) was compared with that of controls (n=33). TM7 consortia were examined using molecular techniques based on 16S rRNA genes, including clone libraries, sequencing and in situ hybridization. TM7 molecular signatures could be cloned from mucosal samples of both IBD patients and controls, but the composition of the clone libraries differed significantly. Taxonomic analysis of the sequences revealed a higher diversity of TM7 phylotypes in CD (23 different phylotypes) than in UC (10) and non-IBD controls (12). All clone libraries showed a high number of novel sequences (21 for controls, 34 for CD and 29 for UC). A highly atypical base substitution for bacterial 16S rRNA genes associated with antibiotic resistance was detected in almost all sequences from CD (97.3 %) and UC (100 %) patients compared to only 65.1 % in the controls. TM7 bacteria might play an important role in IBD similar to that previously described in oral inflammation. The alterations of TM7 bacteria and the genetically determined antibiotic resistance of TM7 species in IBD could be a relevant part of a more general alteration of bacterial microbiota in IBD as recently found, e.g. as a promoter of inflammation at early stages of disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19018031     DOI: 10.1099/jmm.0.47719-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  81 in total

1.  Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis.

Authors:  Hideyuki Nemoto; Keiko Kataoka; Hideki Ishikawa; Kazue Ikata; Hideki Arimochi; Teruaki Iwasaki; Yoshinari Ohnishi; Tomomi Kuwahara; Koji Yasutomo
Journal:  Dig Dis Sci       Date:  2012-05-24       Impact factor: 3.199

2.  The colonic mucus protection depends on the microbiota.

Authors:  Ana M Rodríguez-Piñeiro; Malin E V Johansson
Journal:  Gut Microbes       Date:  2015

Review 3.  Ecology of the Oral Microbiome: Beyond Bacteria.

Authors:  Jonathon L Baker; Batbileg Bor; Melissa Agnello; Wenyuan Shi; Xuesong He
Journal:  Trends Microbiol       Date:  2017-01-11       Impact factor: 17.079

Review 4.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

5.  Cultivation of a human-associated TM7 phylotype reveals a reduced genome and epibiotic parasitic lifestyle.

Authors:  Xuesong He; Jeffrey S McLean; Anna Edlund; Shibu Yooseph; Adam P Hall; Su-Yang Liu; Pieter C Dorrestein; Eduardo Esquenazi; Ryan C Hunter; Genhong Cheng; Karen E Nelson; Renate Lux; Wenyuan Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

6.  Penetrability of the inner mucus layer: who is out there?

Authors:  Hai Li; Julien P Limenitakis; Stephanie C Ganal; Andrew J Macpherson
Journal:  EMBO Rep       Date:  2015-01-08       Impact factor: 8.807

7.  The beneficial effects of ultraviolet light supplementation on bone density are associated with the intestinal flora in rats.

Authors:  Jingjing Cui; Yuming Fu; Zhihao Yi; Chen Dong; Hong Liu
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-24       Impact factor: 4.813

8.  Suppression of the gut microbiome ameliorates age-related arterial dysfunction and oxidative stress in mice.

Authors:  Vienna E Brunt; Rachel A Gioscia-Ryan; James J Richey; Melanie C Zigler; Lauren M Cuevas; Antonio Gonzalez; Yoshiki Vázquez-Baeza; Micah L Battson; Andrew T Smithson; Andrew D Gilley; Gail Ackermann; Andrew P Neilson; Tiffany Weir; Kevin P Davy; Rob Knight; Douglas R Seals
Journal:  J Physiol       Date:  2019-02-27       Impact factor: 5.182

Review 9.  Saccharibacteria (TM7) in the Human Oral Microbiome.

Authors:  B Bor; J K Bedree; W Shi; J S McLean; X He
Journal:  J Dent Res       Date:  2019-03-20       Impact factor: 6.116

10.  Alterations of the Subgingival Microbiota in Pediatric Crohn's Disease Studied Longitudinally in Discovery and Validation Cohorts.

Authors:  Judith Kelsen; Kyle Bittinger; Helen Pauly-Hubbard; Leah Posivak; Stephanie Grunberg; Robert Baldassano; James D Lewis; Gary D Wu; Frederic D Bushman
Journal:  Inflamm Bowel Dis       Date:  2015-12       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.